Evidence map›Paper›PMID 34025199›Full record

ArticleYonago acta medica2021

Endoscopic Treatment of Sinonasal Leiomyosarcoma: A Case Report in Light of the Literature.

Nobuo Ohta, Naoya Noguchi, Senri Shinohara, Kazuhiro Murakami, Miho Nakazumi, Takahiro Suzuki, Teruyuki Sato, Kazue Ise, Yuriko Kagaya, Ryo Tamura and 2 more

Abstract readCase Reports
In one paragraph

Article in Yonago acta medica, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Nobuo OhtaDivision of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-8536, Japan.
Naoya NoguchiDivision of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-8536, Japan.
Senri ShinoharaDivision of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-8536, Japan.
Kazuhiro MurakamiDivision of Pathology, Tohoku Medical and Pharmaceutical University, Sendai 981-8536, Japan.
Miho NakazumiDivision of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-8536, Japan.
Takahiro SuzukiDivision of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-8536, Japan.
Teruyuki SatoDivision of Otolaryngology, Tohoku Medical and Pharmaceutical University, Sendai 981-8536, Japan.
Kazue IseDivision of Pathology, Tohoku Medical and Pharmaceutical University, Sendai 981-8536, Japan.
Yuriko KagayaDivision of Radiology, Tohoku Medical and Pharmaceutical University, Sendai 981-8536, Japan.
Ryo TamuraDivision of Radiology, Tohoku Medical and Pharmaceutical University, Sendai 981-8536, Japan.
Keigo MurakamiDivision of Pathology, Tohoku Medical and Pharmaceutical University, Sendai 981-8536, Japan.
Yasuhiro NakamuraDivision of Pathology, Tohoku Medical and Pharmaceutical University, Sendai 981-8536, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A 49-year-old Japanese man presented with a rare case of sinonasal leiomyosarcoma with left nasal bleeding for 12 months. He had no history of irradiation or malignancies, including retinoblastoma. Preoperative histological examination suggested vascular leiomyoma. Complete resection with endoscopic surgery was performed. Histological examination during the operation suggested that the tumor was a leiomyoma. However, immunohistochemical staining for α smooth muscle actin and desmin were helpful in establishing a definitive diagnosis of sinonasal leiomyosarcoma. The resection margins were positive for tumor cells. Staging with CT of the neck and thorax, ultrasound of the abdomen, and MRI of the head ruled out metastases. Second endoscopic tumor resection surgery was performed for positive resection margins. The patient's condition was successfully managed with additional excision, and he remains well with no evidence of recurrence and metastasis 36 months after treatment. Endoscopic management should be considered in suitable cases.

Indexed as

endoscopic surgeryinonasal leiomyosarcomanasal bleeding

Identifiers

PMID34025199
PMCPMC8128653

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.